KYTX
Kyverna TherapeuticsANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
KYTX vs peer average
82/100
KYTX vs. peer average (A vs. C)
Grade spread
A 3 · B 1 · C 3 · D 1 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ZVRA is the first available peer comparator.
Rare-disease biotech comparator with commercial/regulatory milestones influencing valuation; helpful for how small-cap biotech stocks rerate around discrete filings, but still only a partial operating match.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
KYTX
Kyverna Therapeutics
ZVRA
Zevra Therapeutics
Grade
A
A
Momentum
65
75
Value
41
41
Sentiment
81
70
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs ZVRA
KYTX / ZVRA
Grade Position
Above peers
KYTX vs. peer average (A vs. C)
82/100
Momentum
65
ZVRAValue
41
KYTXSentiment
81
KYTXRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs KYTX
ZVRA is the first peer returned for this comparison set.